US pharmacies are at risk of compromising patient safety by not giving enough attention to nonsterile compounding standards (USP General Chapter <795>). With a focus on sterile compounding and hazardous drug handling, many pharmacies are unprepared for the upcoming nonsterile compounding guidelines effective from November 1, 2023. Pharmacists should assess if nonsterile compounding takes place in their facility, ensuring compliance with scope, purchase history, and dispense history. Properly equipping designated areas and equipment is crucial. Staff must be well-trained and competent in nonsterile compounding, with regular training, cleaning, and documentation to meet the new standards. Terlumina operationalizes the assessments needed and helps pharmacies achieve compliance for success in meeting these newest USP standards. Stay updated here!
Latest News
- Boost Compliance & Operational Efficiency in Pharmacy with Terlumina | Rx Compliance Platform! 🚀
- Introducing Terlumina | Rx 17x Version Demo
- Understanding USP Chapter Regulations in the US: A Comprehensive Overview
- White Paper: How USP Standards are Regulated
- USP Compliance in Pharmacy: Understanding State Inspections in Relation to USP Guidelines P4.
- USP Compliance In Pharmacy: How JCO and ACHC Survey Pharmacies P3.
- USP Compliance in Pharmacy: Federal Oversight P2.
- USP Compliance in Pharmacy: Federal Oversight P1.
- Introduction to USP Compliance in Pharmacy: Insights and Best Practices
- Compliance Safety Nets: From Zip Line Adventures To Pharmacy Solutions